Moderna nabs funding to make vaccine against China coronavirus

The Coalition for Epidemic Preparedness Innovations (CEPI), a public-private coalition aimed at accelerating the development of vaccines, has agreed to fund the manufacture of Moderna’s (MRNA -1.8%) mRNA vaccine against the coronavirus causing the outbreak in China, named 2019-nCoV.

NIH’s National Institute of Allergy and Infectious Diseases (NIAID), Moderna’s collaborator on the design of the vaccine, will conduct IND-enabling studies as well as a Phase 1 clinical trial.

https://seekingalpha.com/news/3533957-moderna-nabs-funding-to-make-vaccine-against-china-coronavirus